HighTower Advisors’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$166K Buy
78,760
+1,385
+2% +$2.92K ﹤0.01% 3340
2025
Q1
$94.4K Buy
77,375
+54,889
+244% +$67K ﹤0.01% 3343
2024
Q4
$29K Buy
+22,486
New +$29K ﹤0.01% 3431
2018
Q4
Sell
-9,905
Closed -$60K 2137
2018
Q3
$60K Buy
+9,905
New +$60K ﹤0.01% 2082